Azimutus is a leading independent advisory firm specializing in M&A transaction advisory and growth capital.
We help our clients realize their strategic goals and create value through M&A transactions. We work for leading local companies, multinational corporations and private equity funds.
Azimutus was established in 2004 and since then has delivered over 150 projects. We support our clients in buy-side and sell-side processes, as well as in the area of related strategic advisory. We are able to undertake complex assignments.
We successfully execute projects in Europe, having access to both global industry and financial investors, as well as attractive acquisition targets.
Azimutus Biotech & Healthcare. Based in Oxford and with strong links with the Oxford-Cambridge-London golden triangle, our senior specialist team has extensive Biotech, Healthcare and Big Pharma experience and close ties to the European and US venture capital ecosystem.